このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Eris Lifesciences マネジメント
マネジメント 基準チェック /44
現在、CEO に関する十分な情報がありません。
主要情報
Amit Bakshi
最高経営責任者
₹48.8m
報酬総額
| CEO給与比率 | 35.9% |
| CEO在任期間 | 17.4yrs |
| CEOの所有権 | 42.9% |
| 経営陣の平均在職期間 | 7.8yrs |
| 取締役会の平均在任期間 | 3.7yrs |
経営陣の近況
Recent updates
Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
May 24
Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price
May 10An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued
Mar 14Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report
Feb 15Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)
Dec 28Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Dec 07Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Nov 11Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Jul 20Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?
Nov 20These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely
Jun 20A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)
Feb 24Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?
Dec 28Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today
Sep 23If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late
May 26Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Apr 17Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?
Mar 12Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?
Feb 25Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar
Feb 12Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results
Jan 30
Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares
Jan 17Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay
Dec 30Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?
Dec 10Eris Lifesciences (NSE:ERIS) Shareholders Booked A 25% Gain In The Last Year
Nov 23Is It Worth Buying Eris Lifesciences Limited (NSE:ERIS) For Its 1.1% Dividend Yield?
Oct 22How Does Eris Lifesciences' (NSE:ERIS) CEO Salary Compare to Peers?
Oct 01How Much Are Eris Lifesciences Limited (NSE:ERIS) Insiders Taking Off The Table?
Sep 14Investor Optimism Abounds Eris Lifesciences Limited (NSE:ERIS) But Growth Is Lacking
Aug 22Eris Lifesciences Limited (NSE:ERIS) Looks Interesting, And It's About To Pay A Dividend
Aug 08Should You Buy Eris Lifesciences Limited (NSE:ERIS) For Its Upcoming Dividend?
Aug 08CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹4b |
| Dec 31 2023 | n/a | n/a | ₹4b |
| Sep 30 2023 | n/a | n/a | ₹4b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹49m | ₹17m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹4b |
| Mar 31 2022 | ₹46m | ₹26m | ₹4b |
| Dec 31 2021 | n/a | n/a | ₹4b |
| Sep 30 2021 | n/a | n/a | ₹4b |
| Jun 30 2021 | n/a | n/a | ₹4b |
| Mar 31 2021 | ₹27m | ₹27m | ₹4b |
| Dec 31 2020 | n/a | n/a | ₹3b |
| Sep 30 2020 | n/a | n/a | ₹3b |
| Jun 30 2020 | n/a | n/a | ₹3b |
| Mar 31 2020 | ₹49m | ₹18m | ₹3b |
| Dec 31 2019 | n/a | n/a | ₹3b |
| Sep 30 2019 | n/a | n/a | ₹3b |
| Jun 30 2019 | n/a | n/a | ₹3b |
| Mar 31 2019 | ₹49m | ₹18m | ₹3b |
| Dec 31 2018 | n/a | n/a | ₹3b |
| Sep 30 2018 | n/a | n/a | ₹3b |
| Jun 30 2018 | n/a | n/a | ₹3b |
| Mar 31 2018 | ₹49m | ₹11m | ₹3b |
報酬と市場: Amitの 総報酬 ($USD 584.49K ) は、 Indian市場 ($USD 455.08K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Amitの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Amit Bakshi (48 yo)
17.4yrs
在職期間
₹48,776,648
報酬
Mr. Amit Indubhushan Bakshi serves as Chairman and Managing Director at Eris Lifesciences Limited. Mr. Bakshi has an extensive experience of Indian Pharmaceutical industry and handles Strategic Management...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & MD | no data | ₹48.78m | 42.87% ₹ 59.2b | |
| President | no data | ₹12.31m | データなし | |
| Chief Financial Officer | 7.8yrs | ₹14.35m | データなし | |
| Executive Director & COO | 3.1yrs | ₹44.85m | データなし | |
| Compliance Officer & Company Secretary | 7.8yrs | データなし | データなし | |
| President of Sales & Marketing | no data | ₹11.24m | データなし | |
| Executive Director | no data | ₹12.40m | 4.37% ₹ 6.0b | |
| Whole Time Director | no data | ₹6.99m | 3.28% ₹ 4.5b | |
| Senior Vice President | no data | ₹12.64m | データなし | |
| Vice President | no data | ₹13.30m | データなし | |
| Vice President | no data | ₹10.67m | データなし | |
| Vice President | no data | ₹13.12m | データなし |
7.8yrs
平均在職期間
50.5yo
平均年齢
経験豊富な経営陣: ERISの経営陣は経験豊富で経験豊富です（平均在職期間は7.8年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & MD | 17.4yrs | ₹48.78m | 42.87% ₹ 59.2b | |
| Executive Director & COO | 3.5yrs | ₹44.85m | データなし | |
| Executive Director | 17.4yrs | ₹12.40m | 4.37% ₹ 6.0b | |
| Whole Time Director | 3.8yrs | ₹6.99m | 3.28% ₹ 4.5b | |
| Independent Director | 6.2yrs | ₹3.98m | データなし | |
| Independent Director | 1.9yrs | ₹2.82m | データなし | |
| Independent Director | 3.4yrs | ₹4.53m | データなし | |
| Independent Director | 3.5yrs | ₹4.20m | データなし |
3.7yrs
平均在職期間
50yo
平均年齢
経験豊富なボード: ERISの 取締役会 は 経験豊富 であると考えられます ( 3.7年の平均在任期間)。